In its latest weekly update, the Global Polio Eradication Initiative (GPEI) said today that Pakistan recorded three new cases of wild poliovirus type 1 (WPV1) this week, and the Democratic Republic of the Congo (DRC) and the Central African Republic recorded new cases of vaccine-derived poliovirus type 2 (cVDPV2).
Health officials in New York's Rockland County yesterday announced a new measles case, which involves an international traveler and is separate from a large outbreak that ended in September.
The patient visited a synagogue in Monsey, New York, possible exposing others from Sep 20 to Sep 21. Monsey is about 40 miles from New York City.
The Global Polio Eradication Initiative (GPEI) said in its latest update today that four countries reported a total of eight new polio cases in the previous week, including vaccine-derived polio cases in the Democratic Republic of the Congo (DRC) and the Central African Republic.
Experts say the cost of a scale-up is $34 billion but would pay for itself 8 times over.
The Pfizer Foundation this week announced $2 million in grants to help non-governmental organizations, non-profits, and social enterprises in low- and middle-income countries address infectious disease challenges, including the growing threat of antimicrobial resistance (AMR).
An investigation in Cairo has identified vancomycin-resistant Staphylococcus aureus (VRSA) in camel meat samples and slaughterhouse workers, Egyptian researchers reported in Antimicrobial Resistance and Infection Control.
Scientists are seeing high rates of treatment failure as they struggle to eliminate the disease in the region.
In more bad news for polio eradication efforts, several countries reported a slew of new polio cases in the last week, according to the Global Polio Eradication Initiative's (GPEI's) weekly report. A total of 19 cases in 6 countries, as well as several polio detections in heathy case contacts, were recorded across the Middle East, Africa, and Asia.
The efficacy of malaria vaccine RTS,S/AS01 in infants and children is sustained for up to 7 years after vaccination, according to an extension study published Jul 9 in The Lancet Infectious Diseases following a previous phase 3 study.
The vaccine "has the potential to save tens of thousands of children's lives."